BMT Class

February 25, 2021 to February 26, 2021

Target Audience

Registered Nurses

Learning Objectives

After attending this event, the learners will be able to:

  • Define hematopoietic progenitor cell transplantation (HPCT) and hematopoetic progenitor cells
  • Describe the types of HPCT and HPC sources and indications for HPCT
  • Describe the history of HPCT
  • Describe the indication and usage of mesenchymal cells
  • List indications for HPCT and best explain the indications to patients and families
  • Describe hematopoetic progenitor cells sources
  • Describe advances in new therapies with dendritic cell and immune therapies
  • Define human leukocyte antigen (HLA)
  • Describe genetic inheritance of HLA and better understand HLA typing
  • Describe the process of donor identification and selection for allogenic marrow, peripheral blood stem cell (PBSC), and cord blood transplant
  • Identify specimens used for HLA typing
  • Discuss the purpose of pre-transplant evaluation for HPCT patients
  • Describe the components of a patient evaluation for potential HPCT to patient and families
  • Describe the HPC donor evaluation process
  • Identify safety issues in pediatric apheresis and when to involve the professional practice team for additional support
  • Identify potential barriers to HPCT
Course summary
Available credit: 
  • 15.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 15.25 Attendance
Course opens: 
02/25/2021
Course expires: 
03/12/2021
Event starts: 
02/25/2021 - 7:00am
Event ends: 
02/26/2021 - 3:00pm
UPMC Children's Hospital of Pittsburgh
4401 Penn Ave
Pittsburgh , PA
United States

ANCC

Available Credit

  • 15.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 15.25 Attendance
Please login or register to take this course.